Bill Text: AZ SB1251 | 2024 | Fifty-sixth Legislature 2nd Regular | Introduced
Bill Title: 340B drugs; covered entities; distribution
Spectrum: Partisan Bill (Republican 2-0)
Status: (Introduced) 2024-01-30 - Senate read second time [SB1251 Detail]
Download: Arizona-2024-SB1251-Introduced.html
|
REFERENCE TITLE: 340B drugs; covered entities; distribution |
|
State of Arizona Senate Fifty-sixth Legislature Second Regular Session 2024
|
|
SB 1251 |
|
|
|
Introduced by Senators Shope: Shamp
|
An Act
amending title 32, chapter 18, article 3, Arizona Revised Statutes, by adding section 32-1980; relating to the Arizona state board of pharmacy.
(TEXT OF BILL BEGINS ON NEXT PAGE)
Be it enacted by the Legislature of the State of Arizona:
Section 1. Title 32, chapter 18, article 3, Arizona Revised Statutes, is amended by adding section 32-1980, to read:
32-1980. 340B drug distribution; interference prohibited; enforcement; definitions
A. A manufacturer, repackager, third-party logistics provider or wholesale distributor, or an agent or affiliate of a manufacturer, repackager, third-party logistics provider or wholesale distributor, may not, either directly or indirectly, do either of the following:
1. Deny, restrict, prohibit, discriminate against or otherwise limit the acquisition of a 340B drug by or delivery of a 340B drug to a 340B covered entity, a pharmacy contracted with a 340B covered entity or a location authorized by the 340B covered entity to receive 340B drugs unless the receipt of the 340B drug is prohibited by the United States department of health and human services.
2. Require a 340B covered entity to submit any claims or utilization data as a condition for allowing the acquisition of a 340B drug by or delivery of a 340B drug to a 340B covered entity unless the claims or utilization data sharing is required by the United States department of health and human services.
B. The board shall investigate any complaint of a violation of subsection A of this section by a person or entity that is permitted or licensed by the board and may impose discipline, suspension or revocation on the permitted or licensed person or entity as provided in this chapter.
C. A violation of subsection A of this section is subject to enforcement by the attorney general as an unlawful practice pursuant to section 44-1522. Each package of 340B drugs that is determined to be subject to a prohibited act under subsection A of this section constitutes a separate violation.
D. The board may adopt rules to implement this section.
E. This section does not create a private cause of action against a person or entity acting in violation of subsection A of this section.
F. This section may not be construed or applied to be less restrictive than any federal law as to any person or entity regulated by this section. Limited distribution of a drug required under 21 United States Code section 355-1 is not a violation of this section. Limited distribution of a controlled substance pursuant to a state or federal law or court order is not a violation of this section. This section may not be construed or applied to be in conflict with either:
1. Any applicable federal law and regulations adopted pursuant to that law.
2. Any other law of this state if the state law is compatible with the applicable federal law.
G. For the purposes of this section:
1. "Repackager" has the same meaning prescribed in 21 United States Code section 360eee(16).
2. "340B covered entity" has the same meaning prescribed in section 20-3341.
3. "340B drug" means a drug that is all of the following:
(a) A covered outpatient drug within the meaning of 42 United States Code section 256b.
(b) Has been subject to any offer for reduced prices by a manufacturer under 42 United States Code section 256b(a)(1).
(c) Is purchased by a 340B covered entity, including that it would have been purchased but for the restriction or limitation described in subsection A of this section.
4. "Wholesale distributor" has the meaning prescribed in 21 United States Code section 360eee.
